Optimisation Strategy for Emergency Tracheal Intubation
OSETIM
Effectiveness of an Optimisation Strategy for Emergency Tracheal Intubation on Postintubation Morbidity: A Cluster Randomized Controlled Trial
1 other identifier
interventional
1,500
1 country
22
Brief Summary
This study has to objective to assess, in adults' patients needing tracheal intubation because of vital distress, the effect of a combined strategy to reduce intubation-related morbidity. This strategy will associate systematic use of rocuronium as paralyzing agent to facilitate tracheal intubation, bag face-mask ventilation before intubation and Gum Elastic Bougie (GEB) use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2023
Longer than P75 for not_applicable
22 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 4, 2022
CompletedFirst Posted
Study publicly available on registry
September 14, 2022
CompletedStudy Start
First participant enrolled
January 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
September 24, 2025
September 1, 2025
3.6 years
August 4, 2022
September 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Severe intubation-related complications occurring during the first hour after intubation
Proportion of patients with severe intubation-related complications occurring during the first hour after intubation The severe intubation-related complications are: * Cardiac arrest. * At least one arterial hypotension episode defined by systolic blood pressure\<90 mmHg. * At least one hypoxemia episode defined by an occurrence of a new episode of oxygen. * Saturation \< 90%. * Severe cardiac arrhythmia: ventricular tachycardia. * Pulmonary aspiration, reported by the physician. * Esophageal intubation. * Unintentional extubation. Severe intubation-related complications will be recorded by the emergency physician in charge of the patient.
Day 0
Secondary Outcomes (10)
Difficulty of the intubation process - Intubation Difficulty
Day 0
Difficulty of the intubation process - Intubation conditions assessed by the Copenhagen
Day 0
Difficulty of the intubation process - Alternative techniques.
Day 0
Difficulty of the intubation process - Intubation attempts
Day 0
Difficulty of the intubation process - Intubation failures under direct laryngoscopy.
Day 0
- +5 more secondary outcomes
Study Arms (2)
Treatment group
EXPERIMENTALCombination rapid sequence intubation (RSI) with use of rocuronium and the bag-mask ventilation between induction and Gum Elastic Bougie GEB will be systematically used at the first attempt to facilitate intubation.
Control Group
ACTIVE COMPARATORPhysicians will be reminded of the current recommendations for emergency intubation: Rapid sequence intubation (RSI) using succinylcholine and use of GEB to facilitate intubation in case of intubation failure under direct laryngoscopy.
Interventions
Arterial pressure, arterial oxygen saturation, heart rate
Rapid sequence intubation (RSI) will be performed with use of rocuronium as paralytic agent (1.2 mg/ kg). Bag-mask ventilation between induction and laryngoscopy will be performed. The GEB will be systematically used at the first attempt to facilitate intubation.
Rapid sequence intubation (RSI) using succinylcholine as a paralytic agent (1 mg/kg), no systematic bag-mask ventilation between induction and laryngoscopy, use of GEB to facilitate intubation in case of intubation failure under direct laryngoscopy.
Eligibility Criteria
You may qualify if:
- Patient adult (≥ 18 years) presenting with vital distress requiring emergency tracheal intubation as assessed by the emergency physician in the out-of-hospital setting.
- Patient with all conditions (trauma, dyspnea, coma, overdoses, and shock) except those in cardiac arrest will be included.
You may not qualify if:
- Patient presenting of a contraindication to succinylcholine, and/or rocuronium, and/or sugammadex (rocunorium antagonist).
- Patient who have contraindication to bag face mask ventilation before intubation (ongoing emesis, hematemesis, or hemoptysis).
- Patient that are not members of a medical aid scheme (beneficiary or main member).
- Patient under specific protection measures: pregnant, parturient or nursing women; legal protection or deprived of liberty: patient under judicial protection, patient under guardianship/curatorship.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (22)
CHU d'Angers
Angers, 49933, France
CH Carnelle Portes de l'Oise
Beaumont-sur-Oise, 95260, France
AP-HP - Hôpital Avicenne
Bobigny, 93000, France
CHU de Bordeaux - Hôpital Pellegrin
Bordeaux, 33000, France
CH de Pontoise René Dubos
Cergy-Pontoise, 95303, France
AP-HP - Hôpital Henri Mondor
Créteil, 94000, France
CHU de Dijon
Dijon, 21000, France
GH Eaubonne Montmorency Hôpital Simone VEIL
Eaubonne, 95600, France
AP-HP - Hôpital Raymond Poincaré
Garches, 92380, France
CHU de Grenoble - Hôpital Nord La Tronche
La Tronche, 38700, France
CH de Versailles - Site André Mignot
Le Chesnay, 78157, France
HCL - Hôpital Edouard Herriot
Lyon, 69003, France
GH Sud Ile de France
Melun, 77000, France
CHU de Montpellier Site Lapeyronie
Montpellier, 34000, France
CHU de Nantes - Hôpital Hôtel Dieu
Nantes, 44093, France
AP-HP - Hôpital Lariboisière
Paris, 75013, France
AP-HP - Hôpital Pitié-Salpétrière
Paris, 75013, France
AP-HP - Hôpital Necker
Paris, 75730, France
CHU Poitiers - Hôpital la Milétrie
Poitiers, 86021, France
CHU de la Réunion - site Sud
Saint-Pierre, 97448, France
GH Sélestat Obernai
Sélestat, 67 600, France
CHU Toulouse - Hôpital Purpan
Toulouse, 31059, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Xavier COMBES, Pr
Université Hospital, Bordeaux
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 4, 2022
First Posted
September 14, 2022
Study Start
January 14, 2023
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
September 24, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share